In several human cancers, including glioblastoma, colorectal cancer, breast cancer, and lung cancer, the EGFR gene is often amplified and mutated and the EGFR protein is overexpressed, leading to chronic receptor activation, excessive signaling, and the promotion of neoplastic transformation [156,158,159]. The gene discussed is EGFR; the disease is breast carcinoma.